BDBM86854 1-(2,4-dimethoxyphenyl)-3-(4-(4-(2-isopropoxyphenyl)piperazin-1-yl)cyclohexyl)urea::CAS_16041090::NSC_16041090
SMILES COc1ccc(NC(=O)NC2CCC(CC2)N2CCN(CC2)c2ccccc2OC(C)C)c(OC)c1
InChI Key InChIKey=HZACYYQCKLSFDB-UHFFFAOYSA-N
Data 8 KI
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 8 hits for monomerid = 86854
TargetAlpha-1D adrenergic receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
TargetAlpha-1A adrenergic receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
TargetAlpha-1D adrenergic receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
TargetAlpha-1A adrenergic receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
TargetAlpha-1B adrenergic receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
TargetD(2) dopamine receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
TargetAlpha-1B adrenergic receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
TargetD(2) dopamine receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
Johnson & Johnson Pharmaceutical Research and Development
Curated by PDSP Ki Database
